Related Experiment Video
Updated: May 31, 2026

Cell-Free DNA Integrity Analysis in Urine Samples
Published on: January 5, 2017
Nectin-4 Positivity in Genitourinary Malignancies: A Systematic Review
Emanuele Crupi1,2, Tiago Costa de Padua1, Laura Marandino1
1Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.
Nectin-4 (N4) is highly expressed in urothelial carcinoma of the bladder (UBC), particularly in metastatic stages. Non-urothelial genitourinary cancers generally show lower N4 positivity, suggesting N4 as a potential target for UBC therapies.
Area of Science:
- Oncology
- Genitourinary Cancer Research
- Molecular Diagnostics
Background:
- Aberrant nectin-4 (N4) expression is identified in various cancers, positioning it as a promising target for antibody-drug conjugates.
- N4 is particularly relevant in urothelial carcinoma of the bladder (UBC), but data on its prevalence in other genitourinary (GU) malignancies are scarce.
Conclusions:
- Non-urothelial genitourinary (GU) cancers generally demonstrate lower nectin-4 (N4) positivity than urothelial carcinoma (UC).
- N4 expression in bladder cancer varies with tumor stage and the presence of histologic subtypes (HS).
- Further prospective studies are warranted to fully elucidate the predictive and prognostic significance of N4 in GU malignancies.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Nursing Assessment of the Genitourinary System I: Health History
Nursing Assessment of the Genitourinary System II: Inspection and Palpation
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Imaging Studies IV: Magnetic Resonance Imaging

